Episode Summary
Executive Summary: Peter Atiyah and Inigo San Millan discuss why The Drive is listener-supported, then dive deep into mitochondrial physiology, exercise zones, lactate, and metabolic health. The conversation links elite endurance performance to diabetes, cancer, and aging, arguing that zone 2 training is a practical proxy for mitochondrial function and a powerful tool for improving metabolic flexibility.
Main Topics: Listener-supported podcast model (Priority: 3/5): Atiyah explains why the show avoids ads, emphasizing trust, honesty, and alignment with his values. Members fund the podcast and receive enhanced show notes, transcripts, AMA access, and product discounts. Inigo San Millan’s athletic background and path to physiology (Priority: 3/5): San Millan describes growing up in Spain, playing in Real Madrid’s academy, briefly racing professionally, and then moving into sports medicine and exercise physiology, which shaped his lifelong focus on elite performance. Energy systems, muscle fibers, and aerobic vs anaerobic metabolism (Priority: 5/5): The discussion clarifies how slow- and fast-twitch fibers use fat and glucose differently, why lactate is produced even under aerobic conditions, and why exercise intensity is better understood as ATP demand rather than oxygen presence/absence. Zone 2 as a marker of mitochondrial function (Priority: 5/5): Zone 2 is framed as the intensity where fat oxidation is maximal and mitochondria are stressed optimally without tipping into heavy glycolysis. It is presented as a functional test of mitochondrial health and a training target for improving it. Lactate as fuel and signaling molecule (Priority: 5/5): The speakers challenge the idea that lactate is merely waste, arguing it is a major fuel and signaling molecule used by the brain, heart, and muscle, and that elevated blood lactate reflects limited local mitochondrial clearance. Diabetes, metabolic syndrome, and the muscle mitochondria (Priority: 5/5): San Millan argues that type 2 diabetes and insulin resistance represent the opposite pole of elite endurance physiology, with poor fat oxidation, low mitochondrial function, and early lactate accumulation. Exercise, especially zone 2, is positioned as a treatment. Metformin, exercise adaptation, and cancer metabolism (Priority: 4/5): Atiyah and San Millan discuss how metformin may raise lactate and potentially blunt exercise adaptations in healthy people, while also exploring lactate’s role in cancer biology and the Warburg effect as a signaling and metabolic phenomenon.
Key Arguments: Elite endurance athletes provide a model of “perfect” mitochondrial function, making them ideal for studying metabolic disease. Zone 2 training is the intensity that maximally stimulates slow-twitch fibers and fat oxidation while improving mitochondrial efficiency. Lactate is not waste; it is a key fuel and signaling molecule that can be oxidized by other tissues and by slow-twitch muscle fibers. High resting RQ/RER and elevated lactate at low workloads are red flags for mitochondrial dysfunction and poor metabolic flexibility. Type 2 diabetes, insulin resistance, and metabolic syndrome are characterized by impaired fat oxidation and early reliance on glucose/lactate pathways. Muscle biopsy and indirect tests like lactate, fat oxidation, and ultrasound-based glycogen assessment can help quantify mitochondrial health. Metformin may increase lactate and alter mitochondrial function; its effects may differ substantially between metabolically healthy people and those with diabetes. Cancer metabolism may involve lactate-driven signaling, not just mitochondrial damage or a simple need for glycolytic building blocks.
Data Points: Podcast funding model: 0 ads; listener-supported membership - Atiyah explains the show relies entirely on subscriber support rather than advertising. University affiliation: 11 years - San Millan says he has been at the University of Colorado for 11 years. Professional cycling experience: 2 years - San Millan raced professionally at a low level for two years. Body weight as cyclist: 143-145 pounds - San Millan describes being very skinny during his racing years. VO2 max test result: ~50 ml/kg/min - Atiyah recalls a VO2 max test where he reached about 50 on the bike. Resting lactate: 0.7-1.0 mmol/L - San Millan says healthy resting lactate is typically around this range. Zone 2 lactate: 1.5-2.0 mmol/L - Zone 2 is described as the range where lactate remains near steady state. Recreational athlete lactate at hard efforts: 10-12 mmol/L - Typical values mentioned for non-elite athletes in maximal protocols. World-class rower lactate: 15-20 mmol/L - San Millan notes elite rowers can reach very high lactate levels in maximal efforts. Elite cyclist zone 2 power: ~300 watts - In the Brooks/San Millan comparison, world-class cyclists reached about 300 W before tipping out of zone 2. Recreational athlete zone 2 power: ~200 watts - Moderately trained athletes reached about 200 W before the same metabolic transition. Type 2 diabetes zone 2 power: ~120 watts - People with type 2 diabetes reached the threshold at much lower power output. Fat oxidation in normal trained athlete: ~0.4 g/min - San Millan describes typical fat max in a trained athlete on a normal diet. Fat oxidation after carbohydrate restriction: ~0.8 g/min - He says short-term carb restriction can increase fat oxidation but reduce performance. Tour de France carbohydrate intake: ~12 g/kg/day - San Millan estimates riders consume about 12 grams of carbohydrate per kilogram per day. Tour de France sugar intake: ~1,500 calories/day from sugar - He estimates roughly 30-50% of carbohydrate intake is simple sugar during racing. Type 1 diabetes insulin use in active patient: ~8-10 units/day - Atiyah cites a highly active type 1 diabetic patient doing daily zone 2 walks. Type 1 diabetes glycogen storage in cyclists: ~25% higher - San Millan reports higher glycogen content in type 1 diabetic cyclists versus non-diabetics in a small study. Muscle mitochondria in elite athletes: 3-4x more and larger - He says well-trained athletes can have three to four times the mitochondria and larger mitochondria than less trained people. Statin muscle symptoms: 5-10% - San Millan cites published estimates of muscle symptoms from statins. U.S. adult population with prediabetes or diabetes: ~50% - He notes about half of U.S. adults have either prediabetes or diabetes. Metformin dose discussed: 1 g twice daily - Atiyah describes his prior metformin regimen before reducing and then stopping around workouts.
Pivotal Quotes: "I have a really hard time advocating for something that I'm not absolutely nuts for." — Peter Atiyah: Explaining why he avoids ad-based sponsorships and prefers listener support. "In order to study other diseases where mitochondrial dysfunction is at the epicenter as well, we need to understand what perfection is in order to understand imperfection." — Inigo San Millan: Describing why elite endurance athletes are the ideal model for studying diabetes and metabolic disease. "Lactate is the most important, if not the most important fuel for the body." — Inigo San Millan: Arguing against the common view of lactate as a waste product.
Implications: Listeners should view zone 2 as both a training target and a diagnostic window into mitochondrial health. The episode suggests exercise, not just medication, is central to preventing and treating metabolic disease, while raising important questions about metformin, statins, and cancer metabolism.
About Peter Attia Drive
Expert insight on health, performance, longevity, critical thinking, and pursuing excellence. Dr. Peter Attia (Stanford/Hopkins/NIH-trained MD) talks with leaders in their fields.